HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 321 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $202,000 | 0.0% | 5,012 | -0.4% | 0.00% | 0.0% |
| Q4 2021 | $202,000 | -11.8% | 5,031 | +0.6% | 0.00% | -33.3% |
| Q2 2021 | $229,000 | +11.7% | 5,000 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $205,000 | -4.2% | 5,000 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $214,000 | +20.9% | 5,000 | -50.0% | 0.00% | 0.0% |
| Q4 2019 | $177,000 | +14.2% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $155,000 | -9.9% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $172,000 | +6.8% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $161,000 | +10.3% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $146,000 | -19.8% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $182,000 | +7.7% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $169,000 | -13.8% | 10,000 | 0.0% | 0.00% | -25.0% |
| Q1 2018 | $196,000 | -3.4% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $203,000 | +16.7% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $174,000 | +35.9% | 10,000 | 0.0% | 0.00% | +33.3% |
| Q2 2017 | $128,000 | -1.5% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $130,000 | +31.3% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $99,000 | -18.2% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $121,000 | +33.0% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $91,000 | -4.2% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $95,000 | -45.1% | 10,000 | 0.0% | 0.00% | -57.1% |
| Q4 2015 | $173,000 | +29.1% | 10,000 | 0.0% | 0.01% | +16.7% |
| Q3 2015 | $134,000 | -40.7% | 10,000 | 0.0% | 0.01% | -40.0% |
| Q2 2015 | $226,000 | +26.3% | 10,000 | -20.0% | 0.01% | +25.0% |
| Q1 2015 | $179,000 | -17.5% | 12,500 | -44.4% | 0.01% | -20.0% |
| Q4 2014 | $217,000 | – | 22,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,305,403 | $233,209,000 | 10.86% |
| BB BIOTECH AG | 7,379,832 | $89,148,000 | 3.13% |
| SENZAR ASSET MANAGEMENT, LLC | 550,544 | $6,650,572,000 | 1.72% |
| SNYDER CAPITAL MANAGEMENT L P | 2,232,114 | $26,964,000 | 1.69% |
| Sterling Global Strategies LLC | 22,000 | $266,000 | 0.98% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 9,290,024 | $112,223,000 | 0.98% |
| MSD Partners, L.P. | 965,000 | $11,657,000 | 0.94% |
| DOHENY ASSET MANAGEMENT /CA | 130,950 | $1,582,000 | 0.81% |
| Taylor Wealth Management Partners | 128,110 | $1,548,000 | 0.69% |
| Bellevue Group AG | 318,000 | $3,841,000 | 0.69% |